Genomics in the era of COVID-19: ethical implications for clinical practice and public health
Gail Geller, Priya Duggal, Chloe L. Thio, Debra Mathews, Jeffrey Kahn, Lisa L. Maragakis, Brian T. Garibaldi
Abstract
Genomic studies of patients with COVID-19, or exposed to it, are underway to delineate host factors associated with variability in susceptibility, infectivity, and disease severity. Here, we highlight the ethical implications-both potential benefits and harms-of genomics for clinical practice and public health in the era of COVID-19.
Topics & Concepts
Coronavirus disease 2019 (COVID-19)GenomicsPublic healthHuman genetics2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)MedicineClinical PracticeDiseaseInfectious disease (medical specialty)BiologyGenomeGeneticsVirologyFamily medicinePathologyGeneOutbreakSARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesSARS-CoV-2 detection and testing